The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis

By Carvalho Dickson   Petronilho Fabricia   Vuolo Francieli   Machado Roberta   Constantino Larissa   Guerrini Remo   Calo Girolamo   Gavioli Elaine   Streck Emílio   Dal-Pizzol Felipe  

Intensive Care Medicine, Vol. 34, Iss. 12, 2008-12 ,pp. : 2284-2290

Springer Publishing Company

Access to resources Recommend Favorite

Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 5, 2018-03 ,pp. : 782-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel and Selective Nociceptin Receptor (NOP) Agonist (1‐(1‐((cis)‐4‐isopropylcyclohexyl)piperidin‐4‐yl)‐1H‐indol‐2‐yl)methanol (AT‐312) Decreases Acquisition of Ethanol‐Induced Conditioned Place Preference in Mice

By  

ALCOHOLISM (ELECTRONIC), Vol. 42, Iss. 2, 2018-02 ,pp. : 461-471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non‐human primates

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 13, 2015-07 ,pp. : 3302-3312

John Wiley & Sons Inc

Access to resources Recommend Favorite

GLP‐1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice

By  

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 74, Iss. 5, 2015-11 ,pp. : 457-466

John Wiley & Sons Inc

Access to resources Recommend Favorite